KR102262697B1 - 이소옥사졸릴-메톡시-니코틴산의 제조 방법 - Google Patents
이소옥사졸릴-메톡시-니코틴산의 제조 방법 Download PDFInfo
- Publication number
- KR102262697B1 KR102262697B1 KR1020207001557A KR20207001557A KR102262697B1 KR 102262697 B1 KR102262697 B1 KR 102262697B1 KR 1020207001557 A KR1020207001557 A KR 1020207001557A KR 20207001557 A KR20207001557 A KR 20207001557A KR 102262697 B1 KR102262697 B1 KR 102262697B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- salt
- solvent
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCOC(C(C=C1N2C1)=CC=C2OCc1c(C=C)[o]nc1*)=O Chemical compound CCOC(C(C=C1N2C1)=CC=C2OCc1c(C=C)[o]nc1*)=O 0.000 description 3
- UGJLFTLQELSQTQ-UHFFFAOYSA-N Cc1c(COc(cc2)ncc2C(N(CC2)CCC2O)=O)c(-c2ccccc2)n[nH]1 Chemical compound Cc1c(COc(cc2)ncc2C(N(CC2)CCC2O)=O)c(-c2ccccc2)n[nH]1 UGJLFTLQELSQTQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/05—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
- C12Y305/05001—Nitrilase (3.5.5.1)
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185992.2 | 2011-10-20 | ||
| EP11185992 | 2011-10-20 | ||
| KR1020147013309A KR20140084209A (ko) | 2011-10-20 | 2012-10-17 | 이소옥사졸릴-메톡시-니코틴산의 제조 방법 |
| PCT/EP2012/070521 WO2013057123A1 (en) | 2011-10-20 | 2012-10-17 | Process for the preparation of isoxazolyl-methoxy-nicotinic acids |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147013309A Division KR20140084209A (ko) | 2011-10-20 | 2012-10-17 | 이소옥사졸릴-메톡시-니코틴산의 제조 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20200008671A KR20200008671A (ko) | 2020-01-28 |
| KR102262697B1 true KR102262697B1 (ko) | 2021-06-11 |
Family
ID=47019026
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207001557A Active KR102262697B1 (ko) | 2011-10-20 | 2012-10-17 | 이소옥사졸릴-메톡시-니코틴산의 제조 방법 |
| KR1020147013309A Ceased KR20140084209A (ko) | 2011-10-20 | 2012-10-17 | 이소옥사졸릴-메톡시-니코틴산의 제조 방법 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147013309A Ceased KR20140084209A (ko) | 2011-10-20 | 2012-10-17 | 이소옥사졸릴-메톡시-니코틴산의 제조 방법 |
Country Status (20)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7403050B2 (ja) * | 2017-08-28 | 2023-12-22 | ユニバーシティ オブ メリーランド ボルチモア | 気分障害のための新規ガンマアミノ酪酸型受容体モジュレーター |
| AU2019286312B2 (en) | 2018-06-13 | 2023-08-17 | F. Hoffmann-La Roche Ag | New isoxazolyl ether derivatives as GABA A alpha5 PAM |
| HU231223B1 (hu) | 2018-09-28 | 2022-01-28 | Richter Gedeon Nyrt. | GABAA A5 receptor modulátor hatású biciklusos vegyületek |
| US12649738B2 (en) | 2020-03-26 | 2026-06-09 | Richter Gedeon Nyrt. | 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABAA α5 receptor modulators |
| TWI901650B (zh) | 2020-03-26 | 2025-10-21 | 匈牙利商羅特格登公司 | 啶及吡啶并〔3,4-c〕嗒衍生物 |
| GB202013765D0 (en) * | 2020-09-02 | 2020-10-14 | Gw Res Ltd | Method of preparing cannabinoids |
| CN116854680A (zh) * | 2022-03-28 | 2023-10-10 | 上海赛默罗生物科技有限公司 | 异噁唑-杂环类衍生物、药物组合物和用途 |
| CN119265168B (zh) * | 2024-11-05 | 2025-06-20 | 江南大学 | 一种新型腈水解酶及其在烟酸生物合成中的应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010112475A1 (en) * | 2009-04-02 | 2010-10-07 | F. Hoffmann-La Roche Ag | Hydroxy-methyl isoxazole derivatives as gaba a modulators |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE315033T1 (de) | 1998-08-07 | 2006-02-15 | Chiron Corp | Subtituierte isoxazole derivate als estrogen rezeptor modulatore |
| US6551804B2 (en) * | 1999-07-12 | 2003-04-22 | E. I. Du Pont De Nemours And Company | Process for preparing 4-cyanopentanoic acid |
| WO2003099793A1 (en) | 2002-05-24 | 2003-12-04 | Takeda Pharmaceutical Company Limited | 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
| UA82292C2 (uk) * | 2004-04-14 | 2008-03-25 | Пфайзер Продактс Инк. | Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти) |
| CA2564429A1 (en) | 2004-05-14 | 2005-12-01 | Irm Llc | Compounds and compositions as ppar modulators |
| PL1802566T3 (pl) | 2004-10-01 | 2009-05-29 | Hoffmann La Roche | Podstawione heksafluoroizopropanolem pochodne eteru |
| ATE485269T1 (de) | 2005-06-27 | 2010-11-15 | Bristol Myers Squibb Co | C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden |
| JP2009508905A (ja) | 2005-09-19 | 2009-03-05 | エフ.ホフマン−ラ ロシュ アーゲー | GABAAα5逆アゴニストとしてのイソオキサゾロ誘導体 |
| CN101277952B (zh) | 2005-10-11 | 2011-09-28 | 弗·哈夫曼-拉罗切有限公司 | 异*唑衍生物 |
| RU2426731C2 (ru) | 2005-12-23 | 2011-08-20 | Ф. Хоффманн-Ля Рош Аг | Производные арил-изоксазоло-4-ил-оксадиазола |
| US7618973B2 (en) | 2007-12-04 | 2009-11-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyrazine derivatives |
| US7943619B2 (en) | 2007-12-04 | 2011-05-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyridazine derivatives |
| JP5301557B2 (ja) * | 2007-12-04 | 2013-09-25 | エフ.ホフマン−ラ ロシュ アーゲー | イソオキサゾロ−ピリジン誘導体 |
| JP2012040448A (ja) * | 2008-11-14 | 2012-03-01 | Yasutaka Sakamoto | マイクロバブル発生装置 |
| KR101354416B1 (ko) | 2009-05-07 | 2014-02-19 | 에프. 호프만-라 로슈 아게 | 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체 |
-
2012
- 2012-10-12 US US13/650,202 patent/US8604062B2/en active Active
- 2012-10-17 JP JP2014536208A patent/JP5923174B2/ja active Active
- 2012-10-17 ES ES12772788.1T patent/ES2613802T3/es active Active
- 2012-10-17 CN CN201280051438.1A patent/CN103889978B/zh active Active
- 2012-10-17 EP EP12772788.1A patent/EP2768827B1/en active Active
- 2012-10-17 RU RU2014118966/04A patent/RU2014118966A/ru not_active Application Discontinuation
- 2012-10-17 AU AU2012321095A patent/AU2012321095B2/en active Active
- 2012-10-17 SG SG11201401626UA patent/SG11201401626UA/en unknown
- 2012-10-17 KR KR1020207001557A patent/KR102262697B1/ko active Active
- 2012-10-17 SI SI201230864A patent/SI2768827T1/sl unknown
- 2012-10-17 MY MYPI2014001152A patent/MY164880A/en unknown
- 2012-10-17 AR ARP120103859A patent/AR088358A1/es active IP Right Grant
- 2012-10-17 BR BR112014009266-4A patent/BR112014009266B1/pt active IP Right Grant
- 2012-10-17 PL PL12772788T patent/PL2768827T3/pl unknown
- 2012-10-17 CA CA2850440A patent/CA2850440C/en active Active
- 2012-10-17 DK DK12772788.1T patent/DK2768827T3/en active
- 2012-10-17 WO PCT/EP2012/070521 patent/WO2013057123A1/en not_active Ceased
- 2012-10-17 HU HUE12772788A patent/HUE031276T2/hu unknown
- 2012-10-17 KR KR1020147013309A patent/KR20140084209A/ko not_active Ceased
- 2012-10-17 MX MX2014004688A patent/MX2014004688A/es unknown
- 2012-10-17 CA CA3112072A patent/CA3112072C/en active Active
-
2014
- 2014-03-20 IL IL231645A patent/IL231645A/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010112475A1 (en) * | 2009-04-02 | 2010-10-07 | F. Hoffmann-La Roche Ag | Hydroxy-methyl isoxazole derivatives as gaba a modulators |
Also Published As
| Publication number | Publication date |
|---|---|
| PL2768827T3 (pl) | 2017-05-31 |
| US20130102778A1 (en) | 2013-04-25 |
| KR20140084209A (ko) | 2014-07-04 |
| ES2613802T3 (es) | 2017-05-26 |
| MY164880A (en) | 2018-01-30 |
| CN103889978B (zh) | 2017-02-15 |
| CA2850440C (en) | 2021-05-04 |
| BR112014009266A2 (pt) | 2017-06-13 |
| AR088358A1 (es) | 2014-05-28 |
| SG11201401626UA (en) | 2014-05-29 |
| MX2014004688A (es) | 2014-05-28 |
| EP2768827A1 (en) | 2014-08-27 |
| BR112014009266A8 (pt) | 2020-04-22 |
| US8604062B2 (en) | 2013-12-10 |
| IL231645A (en) | 2016-09-29 |
| AU2012321095A1 (en) | 2013-05-09 |
| CA2850440A1 (en) | 2013-04-25 |
| IL231645A0 (en) | 2014-05-28 |
| DK2768827T3 (en) | 2017-02-13 |
| JP2014530831A (ja) | 2014-11-20 |
| KR20200008671A (ko) | 2020-01-28 |
| WO2013057123A1 (en) | 2013-04-25 |
| NZ622214A (en) | 2016-08-26 |
| HUE031276T2 (hu) | 2017-07-28 |
| BR112014009266B1 (pt) | 2021-05-04 |
| SI2768827T1 (sl) | 2017-04-26 |
| AU2012321095B2 (en) | 2015-08-20 |
| CN103889978A (zh) | 2014-06-25 |
| EP2768827B1 (en) | 2016-11-23 |
| CA3112072A1 (en) | 2013-04-25 |
| JP5923174B2 (ja) | 2016-05-24 |
| CA3112072C (en) | 2023-06-13 |
| RU2014118966A (ru) | 2015-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2768827T3 (en) | PROCEDURE FOR THE PREPARATION OF ISOXAZOLYL-METHOXY NICOTIC ACIDS | |
| US9926313B2 (en) | Imidazopyridine derivatives as modulators of TNF activity | |
| US9650371B2 (en) | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity | |
| JP5918774B2 (ja) | トリアゾール誘導体及びその神経障害に対する使用 | |
| US20120172355A1 (en) | Aminodihydrothiazine derivatives substituted with a cyclic group | |
| JP6815417B2 (ja) | 新規化合物及びその薬理的に許容される塩 | |
| JPWO2007058305A1 (ja) | シンナミド誘導体の製造方法 | |
| TW201607944A (zh) | 雜芳基衍生物 | |
| JP2014530831A5 (cg-RX-API-DMAC7.html) | ||
| SG11202111162PA (en) | Pyridin-3-yl derivatives | |
| CN114075168A (zh) | 一种吡唑衍生物及其在医药上的应用 | |
| NZ622214B2 (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| HK1193610B (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| HK1193610A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| Class et al. | Patent application title: NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS Inventors: Steven Emiel Van Der Plas (Mechelen, BE) Hans Kelgtermans (Mechelen, BE) Sébastien Jean Jacques Cédric Dropsit Montover (Mechelen, BE) Sebastien Laurent Xavier Martina (Mechelen, BE) Martin James Inglis Andrews (Mechelen, BE) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| A201 | Request for examination | ||
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A18-div-PA0104 St.27 status event code: A-0-1-A10-A16-div-PA0104 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| X091 | Application refused [patent] | ||
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PX0901 | Re-examination |
St.27 status event code: A-2-3-E10-E12-rex-PX0901 |
|
| PX0701 | Decision of registration after re-examination |
St.27 status event code: A-3-4-F10-F13-rex-PX0701 |
|
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 6 |